Hemogenyx Pharmaceuticals PLC Announces Allotment of Shares
LONDON, UK / ACCESSWIRE / February 10, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has allotted 7,741,935 new...
News
XPhyto Adds Mescaline Production to Psychedelic Medicine Programs
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to...
Aptevo Confirms Receipt of Nominations and Proposal Notice
Stockholders Are Not Required to Take Any Action at this Time SEATTLE, WA / ACCESSWIRE / February 9, 2021 /...
Richardson Wealth and Bloom Burton & Co. Announce Strategic Alliance to Expand Wealth Solutions in Healthcare Sector
Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - RF Capital Group Inc. (TSX: RCG) ("RF Capital") today announced that its...
Lucira Health Announces Closing of its Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
Inogen to Announce Fourth Quarter and Year End 2020 Financial Results on February 24th, 2021
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Model N Announces First Quarter Fiscal Year 2021 Financial Results
Total Revenues of $42.7 Million, up 11% Year-over-Year; Subscription Revenues of $31.4 Million, up 12% Year-over-Year SAN MATEO, Calif.--(BUSINESS WIRE)--#earnings--Model...
Beta Bionics Announces the Appointment of Martha Goldberg Aronson as Chair of Its Board of Directors
CONCORD, Mass.--(BUSINESS WIRE)--Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet® bionic...
CPSI Announces Fourth Quarter and Year-End 2020 Results
Company Launches Transformation Initiative with Goal of $80 million in Adjusted EBITDA in 2024; Targets Three-Year Average Organic Recurring Revenue...
Hepion Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference
EDISON, NJ / ACCESSWIRE / February 9, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a clinical stage biopharmaceutical company focused on...
Asia Green Biotechnology Corp. Expands Technology Development Relationship with Pathway Rx Inc. and Swysh Inc. with Agreement to Undertake Initial Toxicity Testing for Migraine Study
CALGARY, AB / ACCESSWIRE / February 9, 2021 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased...
Core One Labs Announces Adding Video Conference Capabilities to Teleconference Call Scheduled for February 10, 2021 1:30 p.m. PST/4:30 p.m. EST
VANCOUVER, BC / ACCESSWIRE / February 9, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt::LD62) (WKN: A2P8K3) (the "Company") is...
AirTank Logs Record Business Despite Pandemic
AirTank Experiences Rapid Growth In Client Roster, Expects More to Come PETERBOROUGH, N.H.--(BUSINESS WIRE)--AirTank, a full-service eCommerce consultancy, announced a...
Aerami Therapeutics Signs License Agreement with Hangzhou Chance Pharmaceuticals Co. Ltd. for Aerami’s PAH (pulmonary arterial hypertension) Drug Device Combination in China
DURHAM, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Aerami Therapeutics, Inc. (“Aerami” or the “Company”) a clinical stage biopharmaceutical company...
Adagene Inc. Announces Pricing of Initial Public Offering
SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene" or the "Company") (Nasdaq: ADAG), a platform-driven, clinical-stage...
CohBar to Present at the BIO CEO & Investor Digital Conference
MENLO PARK, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Arch Oncology to Collaborate with Merck on Phase 1/2 Clinical Trial of Anti-CD47 Antibody AO-176 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Select Solid Tumors
With Encouraging Safety and Anti-tumor Activity for AO-176 Monotherapy in Phase 1 Trial, Advancing AO-176 in Combination with Anti-PD-1BRISBANE, Calif....
Sharps Compliance Announces Appointment of Pat Mulloy, Veteran CEO of Long-Term and Senior Care Businesses, to Board of Directors
HOUSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national...
Resonant Provides Preliminary Full Year 2020 Financial Results, Revenues Increase Over 330% to a Record $3.2 Million
AUSTIN, Texas, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter intellectual...
Agenus Announces New Responses for AGEN1181
6 total confirmed objective clinical responses in colon, ovarian, and endometrial cancersNo complement-mediated toxicities reportedLEXINGTON, Mass., Feb. 09, 2021 (GLOBE...